EPO published patent EP3387993A2 granting Dexcom, Inc. intellectual property protection for polymer membrane compositions used in continuous analyte sensors. The patent covers electrochemical sensors for measuring glucose and other analytes, with claims related to the membrane materials and sensor configurations. Designated states include all EU member states plus Switzerland, Norway, and other European Patent Convention countries.

This is a patent publication rather than a regulatory action imposing obligations. Medical device manufacturers developing competing continuous glucose monitoring products should review the patent claims for potential licensing considerations or design-around strategies. No compliance deadlines or enforcement actions apply to this notice.